Neonatal Abstinence Syndrome: Essentials for the Practitioner
- 1 July 2014
- journal article
- review article
- Published by Pediatric Pharmacy Advocacy Group in The Journal of Pediatric Pharmacology and Therapeutics
- Vol. 19 (3), 147-155
- https://doi.org/10.5863/1551-6776-19.3.147
Abstract
The incidence of neonatal abstinence syndrome (NAS) has increased dramatically during the past 15 years, likely due to an increase in antepartum maternal opiate use. Optimal care of these patients is still controversial because of the available published literature lacking sufficient sample size, placebo control, and comparative pharmacologic trials. Primary treatment for NAS consists of opioid replacement therapy with either morphine or methadone. Paregoric and tincture of opium have been abandoned because of relative safety concerns. Buprenorphine is emerging as a treatment option with promising initial experience. Adjunctive agents should be considered for infants failing treatment with opioid monotherapy. Traditionally, phenobarbital has been used as adjunctive therapy; however, results of clonidine as adjunctive therapy for NAS appear to be beneficial. Future directions for research in NAS should include validating a simplified scoring tool, conducting comparative studies, exploring home management options, and optimizing management through pharmacogenomics.Keywords
This publication has 28 references indexed in Scilit:
- Use of tincture of opium compared to oral morphine for the treatment of neonatal abstinence syndromeJournal of Opioid Management, 2013
- Committee Opinion No. 524Obstetrics & Gynecology, 2012
- Neonatal Abstinence Syndrome after Methadone or Buprenorphine ExposureThe New England Journal of Medicine, 2010
- Revised dose schema of sublingual buprenorphine in the treatment of the neonatal opioid abstinence syndromeAddiction, 2010
- Use of clonidine in the prevention and management of neonatal abstinence syndromeClinical Toxicology, 2009
- Clonidine as an Adjunct Therapy to Opioids for Neonatal Abstinence Syndrome: A Randomized, Controlled TrialPEDIATRICS, 2009
- Maternal Smoking during Pregnancy and Newborn Neurobehavior: Effects at 10 to 27 DaysThe Journal of Pediatrics, 2009
- Sublingual Buprenorphine for Treatment of Neonatal Abstinence Syndrome: A Randomized TrialPEDIATRICS, 2008
- Management of neonatal abstinence syndrome in neonates born to opioid maintained womenDrug and Alcohol Dependence, 2007
- Therapy of the neonatal abstinence syndrome with tincture of opium or morphine dropsDrug and Alcohol Dependence, 2005